Amgen, Inc. (AMGN)
328.97
+4.67
(+1.44%)
USD |
NASDAQ |
Jan 14, 16:00
328.50
-0.47
(-0.14%)
After-Hours: 20:00
Amgen SG&A Expense (TTM): 6.976B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.886B |
| Johnson & Johnson | 23.38B |
| Eli Lilly & Co. | 10.39B |
| Merck & Co., Inc. | 10.70B |
| Regeneron Pharmaceuticals, Inc. | 2.717B |